Porras-Segovia A

Mental Health Research Group, Health Research Institute Jimenez Díaz Foundation, 28040 Madrid, Spain.

2 papers · ORCID

ArticleKetamine

Intranasal Esketamine Versus Other Pharmacological Strategies in Treatment-Resistant Depression with High Suicide Risk: A Six-Month Naturalistic Study.

de Granda-Beltrán AM, Porras-Segovia A, Núñez-Arias D +5

Europe PMC2026
ArticleKetamine

Esketamine use in real-world clinical practice in patients with treatment-resistant depression.

Conejero I, Alvarez García R, Porras-Segovia A +7

Europe PMC2025